TB Alliance
Christopher Cooper has had an extensive work experience in the pharmaceutical industry. Christopher started their career at Ciba-Geigy in 1982 as an Associate Research Scientist before moving to Pfizer Global Research and Development in 1988, where they worked as a Senior Research Investigator for 10 years. In 1998, they joined Bristol-Myers Squibb as an Associate Director, Discovery Chemistry, a role they held for 10 years. Most recently, they have worked at the Global Alliance for TB Drug Development, starting as Director, Chemistry in 2009 and later becoming the Senior Director, Chemistry in 2011.
Christopher Cooper earned a Bachelor of Science magna cum laude in Chemistry from Clemson University between 1976 and 1980. Christopher then pursued a Master of Science degree in Organic Chemistry at Stanford University from 1980 to 1982. Christopher Cooper furthered their education at Stanford University and obtained a Ph.D. in Organic Chemistry from 1984 to 1988.
TB Alliance
We envision a world where no one dies of tuberculosis. However, this cannot be achieved without improved, faster-acting, and affordable tuberculosis drug regimens that are available to all who need them. These new cures can bring renewed health, hope, and prosperity to millions. Since our inception in 2000, TB Alliance has led the global search for and development of new TB regimens, catalyzing the field and convening cross-sector partnerships to forge the progress that is urgently needed for better TB treatments.